Briacell Therapeutics
BCTX
NASDAQ
IPO2023
about BCTX
Briacell Therapeutics develops innovative immunotherapy treatments designed to target and treat various cancers, including melanoma.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.02 | $4.21 | $3.77 | $29.15M | 257.50K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$4.35 | n/a | n/a | 0% | 0% | 0% |